SteroTherapeutics Competitors and Similar CompaniesClear all

SteroTherapeutics's competitors and similar companies include Albireo Pharma, Heron Therapeutics and Ventria Bioscience.

	SteroTherapeutics SteroTherapeutics is a biopharmaceutical company developing therapies for diseases related to metabolic syndrome.	Albireo Pharma Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.	Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.	Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
Founding Date	Founding Date 2016	Founding Date 2003	Founding Date 1983	Founding Date 1993
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Doylestown, US HQ	Locations Boston, US HQ Göteborg, SE	Locations San Diego, US HQ	Locations Junction City, US HQ Aurora, US
Employees	Employees N/A	Employees 5541% increase	Employees 20333% decrease	Employees 244% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 915.9 m	Valuation ($) 268.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.6m (FY, 2021)	Revenue (est.) $154.9m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.4m (FY, 2021)	Cost of goods $41.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $39.2m (FY, 2021)	Gross profit $113.6m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($34m) (FY, 2021)	Net income ($20.2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 40m	Total funding raised N/A	Total funding raised $ 7.7m